INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
Revenue From Contract With Customer Including Assessed Tax |
|
- |
- |
- |
|
Marketing Derivative Gains |
|
- |
- |
- |
|
Marketing Derivative Gain Loss |
|
- |
- |
- |
|
Amortization Of Deferred Revenue |
|
- |
- |
- |
|
Natural Gas Liquids Revenues |
|
- |
- |
- |
|
Oil Revenue |
|
- |
- |
- |
|
Derivative Instruments Gain Loss Recognized On Commodity Derivative Instrument In Income Net |
|
- |
- |
- |
|
Gains Losses On Sales Of Other Assets |
|
- |
- |
- |
|
Other Revenue |
|
- |
- |
- |
|
Total Revenue |
1,194.14 |
1,126.18 |
953.31 |
1,408.35 |
2,085.29 |
Cost of Goods and Services Sold |
661.33 |
671.89 |
663.98 |
645.17 |
642.50 |
Gross
Profit |
532.82 |
454.29 |
289.33 |
763.18 |
1,442.79 |
Selling, Administration, Marketing |
41.16 |
32.26 |
36.16 |
49.28 |
20.37 |
Gain (Loss) on Disposition of Assets |
0.00 |
-0.14 |
-0.22 |
-0.09 |
-1.97 |
Depriciation & Amortization |
174.72 |
176.26 |
171.41 |
167.58 |
-169.21 |
Exploration Expense |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
6.56 |
13.48 |
15.71 |
15.56 |
-66.73 |
Other operatinig exp. /-income |
43.36 |
176.70 |
155.21 |
140.49 |
751.61 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Loss On Contract Termination |
-29.55 |
- |
- |
29.55 |
-5.00 |
Results Of Operations Production Or Lifting Costs |
- |
- |
- |
- |
52.71 |
Operating Lease Expense |
89.12 |
- |
- |
29.32 |
-81.82 |
Loss On Contract Termination And Loss Contingency Loss In Period |
52.61 |
- |
- |
- |
- |
Total operating costs including COS |
1,039.30 |
1,070.44 |
1,042.24 |
1,076.86 |
1,142.46 |
Operating income/-loss
|
154.84 |
55.73 |
-88.94 |
331.49 |
942.83 |
Other Deductions / - Income |
Interest expense |
32.61 |
31.63 |
27.93 |
25.70 |
25.12 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
-32.61 |
-31.63 |
-27.93 |
-25.70 |
-168.97 |
Extinguishment of Debt |
- |
- |
- |
- |
30.79 |
Loss (Income) from Equity Method Investments |
-23.97 |
-22.21 |
-19.10 |
-17.68 |
1,179.80 |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
65.50 |
0.00 |
0.00 |
0.09 |
-1,033.30 |
Total costs & expenses |
1,048.23 |
1,079.87 |
1,051.07 |
1,084.96 |
1,150.77 |
Income /-loss before income taxes |
145.91 |
46.31 |
-97.77 |
323.39 |
934.52 |
Income taxes expenses/-benefit |
29.98 |
13.66 |
-29.83 |
62.18 |
140.39 |
Income after income taxes |
115.93 |
32.64 |
-67.93 |
261.20 |
794.13 |
Net income/-loss
of other equity |
0.00 |
0.00 |
- |
- |
- |
Income/-loss
from cont. Ops. |
115.93 |
32.64 |
-67.93 |
261.20 |
794.13 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
115.93 |
32.64 |
-67.93 |
261.20 |
794.13 |
Noncontrolling interests |
21.17 |
14.83 |
15.15 |
47.77 |
63.83 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
94.76 |
17.81 |
-83.08 |
213.43 |
730.30 |
EBIT |
113.31 |
14.67 |
-125.69 |
297.69 |
765.55 |
EBITD |
113.31 |
14.67 |
-125.69 |
297.69 |
765.55 |
EBITDA |
113.31 |
15.54 |
-124.83 |
298.56 |
766.42 |